title: Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy.
abstract: Leber hereditary optic neuropathy and autosomal dominant optic atrophy are the two most common inherited optic neuropathies. The latter has been associated with mutations in the OPA1 and OPA3 genes. To date, only six families with OPA3-associated dominant optic atrophy have been reported. In order to identify additional families, we performed Sanger sequencing of the OPA3 gene in 75 unrelated optic neuropathy patients. Affected individuals from two families were found to harbour the c.313C > G, p.(Gln105Glu) change in heterozygous state; this genetic defect has been previously reported in four dominant optic atrophy families. Intra- and interfamilial variability in age of onset and presenting symptoms was observed. Although dominant OPA3 mutations are typically associated with optic atrophy and cataracts, the former can be observed in isolation; we report a case with no lens opacities at age 38. Conversely, it is important to consider OPA3-related disease in individuals with bilateral infantile-onset cataracts and to assess optic nerve health in those whose vision fail to improve following lens surgery. The papillomacular bundle is primarily affected and vision is typically worse than 20/40. Notably, we describe one subject who retained normal acuities into the fifth decade of life. The condition can be associated with extraocular clinical features: two affected individuals in the present study had sensorineural hearing loss. The clinical heterogeneity observed in the individuals reported here (all having the same genetic defect in OPA3) suggests that the molecular pathology of the disorder is likely to be complex.
authors.affiliation: Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
authors.forename: Panagiotis I
authors.initials: PI
authors.lastname: Sergouniotis
authors.forename: Rahat
authors.initials: R
authors.lastname: Perveen
authors.forename: Dawn L
authors.initials: DL
authors.lastname: Thiselton
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Giannopoulos
authors.forename: Marios
authors.initials: M
authors.lastname: Sarros
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Davies
authors.forename: Susmito
authors.initials: S
authors.lastname: Biswas
authors.forename: Alec M
authors.initials: AM
authors.lastname: Ansons
authors.forename: Jane L
authors.initials: JL
authors.lastname: Ashworth
authors.forename: I Christopher
authors.initials: IC
authors.lastname: Lloyd
authors.forename: Graeme C
authors.initials: GC
authors.lastname: Black
authors.forename: Marcela
authors.initials: M
authors.lastname: Votruba
mesh_terms: D000328:Adult; D000368:Aged; D004252:DNA Mutational Analysis; D005260:Female; D005799:Genes, Dominant; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D029241:Optic Atrophy, Autosomal Dominant / Q000175:diagnosis* / Q000235:genetics*; D009898:Optic Disk / Q000473:pathology; D010375:Pedigree; D011506:Proteins / Q000235:genetics*; D014792:Visual Acuity / Q000235:genetics; D055815:Young Adult
chemical_list: C443108:OPA3 protein, human; D011506:Proteins